Arkolith/Insider Trading/ARDX/Form 4

Williams Laura A

Chief Patient OfficerARDELYX, INC. (ARDX) · full profile →Form 4 · filed Jan 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$349K
Net Open-Market Flow
-$349K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 8, 2026Sell(S)50K$6.98$349K362K
Jan 8, 2026Option exercise(M)50K$0.99$50K410K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 8, 2026Option exercise(M)0—$062K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001869194-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML